A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Orano Med LLC
Amgen
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Vastra Gotaland Region
Fundación de investigación HM
Rezolute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
RayzeBio, Inc.
Melanoma and Skin Cancer Trials Limited
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
ITM Solucin GmbH
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
RayzeBio, Inc.
Boston Scientific Corporation
Melanoma and Skin Cancer Trials Limited
National Institutes of Health Clinical Center (CC)
Exelixis
University Health Network, Toronto
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
M.D. Anderson Cancer Center
Hoffmann-La Roche
Grupo Espanol de Tumores Neuroendocrinos
Columbia University
Olivia Newton-John Cancer Research Institute
National Institutes of Health Clinical Center (CC)
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cedars-Sinai Medical Center
University of Florida
University of Michigan Rogel Cancer Center
Tata Memorial Hospital
University of Utah